Atlas Trials

A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis

Clinical trial NCT04888806 · UNKNOWN

Trial details

NCT number
NCT04888806
Sponsor
Harbin Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer MetastaticLiver MetastasesLung Metastases
Start date
2021-06-01
Primary completion
2024-06-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.